A review of HIV prevention among young injecting drug users: A guide for researchers

Young people aged 15–24 years account for fifty percent of all new AIDS cases worldwide. Moreover, half of all new HIV infections are associated with injection drug use. The average age for initiation into injecting drug use is 20 years of age. This paper investigates whether HIV prevention programs...

Descripción completa

Detalles Bibliográficos
Autores principales: Dolan, Kate A, Niven, Heather
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1082909/
https://www.ncbi.nlm.nih.gov/pubmed/15774000
http://dx.doi.org/10.1186/1477-7517-2-5
_version_ 1782123780491968512
author Dolan, Kate A
Niven, Heather
author_facet Dolan, Kate A
Niven, Heather
author_sort Dolan, Kate A
collection PubMed
description Young people aged 15–24 years account for fifty percent of all new AIDS cases worldwide. Moreover, half of all new HIV infections are associated with injection drug use. The average age for initiation into injecting drug use is 20 years of age. This paper investigates whether HIV prevention programs have reduced risk behaviours in young people.
format Text
id pubmed-1082909
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-10829092005-04-21 A review of HIV prevention among young injecting drug users: A guide for researchers Dolan, Kate A Niven, Heather Harm Reduct J Review Young people aged 15–24 years account for fifty percent of all new AIDS cases worldwide. Moreover, half of all new HIV infections are associated with injection drug use. The average age for initiation into injecting drug use is 20 years of age. This paper investigates whether HIV prevention programs have reduced risk behaviours in young people. BioMed Central 2005-03-17 /pmc/articles/PMC1082909/ /pubmed/15774000 http://dx.doi.org/10.1186/1477-7517-2-5 Text en Copyright © 2005 Dolan and Niven; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Dolan, Kate A
Niven, Heather
A review of HIV prevention among young injecting drug users: A guide for researchers
title A review of HIV prevention among young injecting drug users: A guide for researchers
title_full A review of HIV prevention among young injecting drug users: A guide for researchers
title_fullStr A review of HIV prevention among young injecting drug users: A guide for researchers
title_full_unstemmed A review of HIV prevention among young injecting drug users: A guide for researchers
title_short A review of HIV prevention among young injecting drug users: A guide for researchers
title_sort review of hiv prevention among young injecting drug users: a guide for researchers
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1082909/
https://www.ncbi.nlm.nih.gov/pubmed/15774000
http://dx.doi.org/10.1186/1477-7517-2-5
work_keys_str_mv AT dolankatea areviewofhivpreventionamongyounginjectingdrugusersaguideforresearchers
AT nivenheather areviewofhivpreventionamongyounginjectingdrugusersaguideforresearchers
AT dolankatea reviewofhivpreventionamongyounginjectingdrugusersaguideforresearchers
AT nivenheather reviewofhivpreventionamongyounginjectingdrugusersaguideforresearchers

Ejemplares similares